Bench-to-bedside review: Chloride in critical illness

Department of Intensive Care, Austin Hospital, Heidelberg, Melbourne, VIC 33084, Australia.
Critical care (London, England) 07/2010; 14(4):226. DOI: 10.1186/cc9052
Source: PubMed

ABSTRACT Chloride is the principal anion in the extracellular fluid and is the second main contributor to plasma tonicity. Its concentration is frequently abnormal in intensive care unit patients, often as a consequence of fluid therapy. Yet chloride has received less attention than any other ion in the critical care literature. New insights into its physiological roles have emerged together with progress in understanding the structures and functions of chloride channels. In clinical practice, interest in a physicochemical approach to acid-base physiology has directed renewed attention to chloride as a major determinant of acid-base status. It has also indirectly helped to generate interest in other possible effects of disorders of chloraemia. The present review summarizes key aspects of chloride physiology, including its channels, as well as the clinical relevance of disorders of chloraemia. The paper also highlights current knowledge on the impact of different types of intravenous fluids on chloride concentration and the potential effects of such changes on organ physiology. Finally, the review examines the potential intensive care unit practice implications of a better understanding of chloride.

1 Follower
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Intravenous fluids are widely administered in the ICU with the intention of preventing or ameliorating acute kidney injury (AKI). This review focuses on recent studies examining fluid administration and renal function in critical illness to critically examine conventional justifications for fluid administration. Early, targeted, resuscitation of inadequate cardiac output in shock may have a beneficial effect on organ function and patient outcome. However, experimental evidence suggests the relationship between fluid administration and an increase in renal oxygen delivery is weak, whereas any beneficial effects from fluid administration can be short lived. Conversely, evidence associating fluid overload and adverse outcomes is strengthening, whereas more restrictive fluid administration does not seem to predispose to clinically significant AKI in many situations. Furthermore, concerns persist that some colloid or high chloride concentration solutions may directly impair renal function independent of volume overload. Adequate volume resuscitation remains a cornerstone to the emergent treatment of critical illness. However, continued fluid administration and positive fluid balances have not been shown to improve renal outcomes and may worsen overall prognosis in AKI. Concerns about renal dysfunction should not deter clinicians from adopting more restrictive approaches to fluid administration.
    Current opinion in critical care 08/2010; 16(4):332-6. DOI:10.1097/MCC.0b013e32833be90b · 3.18 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The present review of fluid therapy studies using balanced solutions versus isotonic saline fluids (both crystalloids and colloids) aims to address recent controversy in this topic. The change to the acid-base equilibrium based on fluid selection is described. Key terms such as dilutional-hyperchloraemic acidosis (correctly used instead of dilutional acidosis or hyperchloraemic metabolic acidosis to account for both the Henderson-Hasselbalch and Stewart equations), isotonic saline and balanced solutions are defined. The review concludes that dilutional-hyperchloraemic acidosis is a side effect, mainly observed after the administration of large volumes of isotonic saline as a crystalloid. Its effect is moderate and relatively transient, and is minimised by limiting crystalloid administration through the use of colloids (in any carrier). Convincing evidence for clinically relevant adverse effects of dilutional-hyperchloraemic acidosis on renal function, coagulation, blood loss, the need for transfusion, gastrointestinal function or mortality cannot be found. In view of the long-term use of isotonic saline either as a crystalloid or as a colloid carrier, the paucity of data documenting detrimental effects of dilutional-hyperchloraemic acidosis and the limited published information on the effects of balanced solutions on outcome, we cannot currently recommend changing fluid therapy to the use of a balanced colloid preparation.
    Critical care (London, England) 10/2010; 14(5):325. DOI:10.1186/cc9230
  • [Show abstract] [Hide abstract]
    ABSTRACT: Zusammenfassung Im Frühjahr 2010 wurden erneut 2 Studien präsentiert, die keine Verbesserung der Sterblichkeit der Patienten mit akut-auf-chronischem Leberversagen zeigten, obwohl sie mit einem Leberunterstützungssystem behandelt wurden. Die Autoren dieses Beitrags schlagen als Ursache für die negativen Studienergebnisse eine unzureichende Entgiftungsfunktion der Verfahren vor. Am Beispiel der Marker Ammoniak und Bilirubin wird erläutert, welche Entgiftungsziele für eine erfolgreiche Therapie anzusetzen sind. Zusätzlich werden weitere notwendige Funktionen eines Leberunterstützungssystems definiert wie Elektrolytausgleich und Kontrolle des Wasser- und Säure-Basen-Haushaltes. Auf die besondere Bedeutung der Vermeidung von Nebenwirkungen wird hingewiesen, da hierdurch die positiven Ergebnisse der Therapie zunichte gemacht werden können. Weitere offene Fragen betreffen die Auswahl der Patienten, des Therapiebeginns oder die Frage einer intermittierenden vs. einer kontinuierlichen Therapie. In diesem Kontext wird auch der derzeitige Stellenwert bioartifizieller Leberunterstützungssysteme besprochen.
    Intensivmedizin + Notfallmedizin 11/2010; 47(8):576-581. DOI:10.1007/s00390-010-0194-1
Show more

Preview (3 Sources)

Available from